Print ISSN:-

Online ISSN:-2455-1732

CODEN : SUJHAW

Issue

Year 2020

Volume: 6 , Issue: 1

  • Article highlights
  • Article tables
  • Article images

Article Access statistics

Viewed: 790

Emailed: 0

PDF Downloaded: 1316

Kumar, Garg, and Sinha: Comparison of echocardiographic changes among hypertensives and healthy controls in Indian population


Introduction

Hypertension is a major risk factor for the development of coronary artery disease (CAD). During hypertension, left ventricular hypertrophy (LVH) is initially a useful compensatory mechanism to abnormal loading conditions, which is also the first step toward the development of overt clinical disease, such as congestive heart failure, ischemic heart disease, cardiac dysrhythmias and stroke.1, 2 The Framingham study has clearly demonstrated that once LVH is recognized clinically by electrocardiography3 or echocardiography4 it becomes a strong predictor for the prognosis of cardiovascular disease.

Use of exercise electrocardiography and nuclear techniques are burdened by a high rate of false-positive responses in the hypertensive population due to reduced coronary flow reserve in the absence of obstructive CAD.5, 6 When compared stress echocardiography (SE) provides similar sensitivity but superior diagnostic specificity.5, 6, 7 The prognostic value of Stress Echocardiography is well established in hypertensive patients with suspected CAD8, 9 as well as in unselected cohorts of hypertensive patients.10, 11

In recent time development of Doppler echocardiography has offered new insights into the pathophysiological and clinical implications affecting hypertensive patients.4 Echocardiography is one of the very first clinical investigation that a hypertensive patient is recommended to undergo. It is obvious that echocardiographic assessment is very important in the clinical management of a hypertensive patients.

The procedure of Echocardiographic assessment of the heart of a hypertensive patient includes two levels assessment. Anatomic approach, includes measurement of the heart cavities and A functional approach, which includes assessment of indices of function. Echocardiographic evaluation of a patient with hypertension includes the following:

Left ventricular hypertrophy, cardiac mass and geometry, Left ventricular function, Left atrial volume and function, the thoracic aorta and coronary artery patency. The development of left ventricular diastolic dysfunction may precede hypertrophy and may be one of the earliest changes associated with hypertensive heart disease. If the left ventricular ejection fraction is initially evaluated <50%, there is an early tenfold increased risk for hospitalization for congestive heart failure as compared to hypertensive patients with a normal ejection fraction.12, 13, 14

Aging and hypertension have been shown to significantly increase aortic diameter, thickness and stiffness of aortic root is a frequent cardiovascular phenotype in hypertensive patients who are referred to echo laboratories for identification of increased cardiovascular morbidity and mortality.15, 16, 17

In addition to describing a parameter as normal or abnormal (reference values) clinical echocardiographic can help to quantify the degree of abnormality in terms of mild, moderate and severe.

Materials and Methods

A cross-sectional study was conducted in the Department of Physiology in collaboration with Echocardiography laboratory of Santosh Medical Hospital Ghaziabad. Sample size was of 200 cases, more than 60 years of age, divided in to two groups as Group 1 comprised of 100 patients with hypertension for more than 5 years and Group 2 had 100 healthy age matched control subjects. Duration of study was from July 2015 through December 2016. After obtaining ethical clearance from Institutional Ethical committee. The selection of the patient was done on the basis of detailed medical history and general physical examination. All subjects were interviewed for personal details such as, age, personal habits including recent and past medical history. All eligible subjects signed informed consent form before commencing the study.

Echocardiography

Types of echocardiography and steps were described to patients in their own language. Patient were made to lie down on a bed in a supine position then the sonographer will spread gel on a device (transducer), the transducer was firmly pressed, aiming an ultrasound beam through the chest to the heart. Prior to the procedure, anthropometric parameters were noted in each subject such as age (in years), height (in centimetres) and Body Mass Index (Quetelet's Index). BMI was calculated using weight and height values by the following formula; BMI = Weight (in kg)Height (in m)2. The Physical parameters were recorded and all the subjects underwent comprehensive echocardiographic examination using the equipment (GE vivid P3 Model No.: H47082LA VP3). All patients were examined in left lateral position using grey scale second –harmonic imaging technique, with the adjustment of image contrast, frequency, depth and sector size for an adequate frame rate and optimal LV border visualization.

The image acquisition was performed during held end –expiration to minimize cardiac respiratory motion. A minimum of at least 3 cardiac cycles were recorded for analysis. M Mode, 2 D (frame rate >50-70 fps), colour Doppler, pulse wave Doppler, pulse wave tissue Doppler was obtained in all cases. Care was taken to avoid LV foreshortening in all apical views.10 The following parameters were recorded; Measurements of left ventricle, Mitral Value: Normal/ Stenosis/ Regurgitation, Aortic Valve: Normal/ Stenosis/Regurgitation, Tricuspid Valve: Normal/ Stenosis/ Regurgitation, Pulmonary Valve: Normal/ Stenosis/ Regurgitation, Right Ventricle: normal/Dilated, Left Atrium: Normal/ Dilated, Interatrial Septum: Intact / defect, Interventricular Septum: Intact/ defect, Left ventricular wall movement: Normal/ Regional Wall Motion Abnormality / global Hypokinesia,18 Pulmonary artery hypertension: Present/ absent.

Statistical analysis

The Data was entered in to MS Excel software and analysis was done using SPSS version 20 software. All the parameters were reported as mean and standard deviation. Differences between the groups were estimated by t-test. A p-value <0.05 was considered statistically significant and p-value > 0.05 was considered non - significant.

Results

The patients were equally divided in two groups, Group 1 comprising of 100 patients and Group 2 comprising of 100 subjects.

Table 1

Age wise distribution

S. No. Group Mean +SD
1 Group 1 (N=100) 54.33+2.85
2 Group 2 (N=100) 54.18+2.54

Table 2

Sex wise distribution

S. No. Group Male Female Total
1 Group 1 (N=100) 86 14 100
2 Group 2 (N=100) 91 9 100

Table 3

Showing Comparison of L.A. Diameter among cases and controls

S. No. Group L. A. Diameter (CM) Mean +SD p value
1 Group 1 (N=100) 2.94+0.27 0.000
2 Group 2 (N=100) 3.43+0.32

Table 4

Showing Comparison of AORTIC ROOT

S. No. Group Aortic Root (cm) Mean +SD p value
1 Group 1 (N=100) 2.94+0.27 0.04
2 Group 2 (N=100) 3.02+0.32

Table 5

Showing Comparison of thickness of interventricular septum in diastole (IVSD)

S. No. Group I.V.S.D. (CM) Mean +SD p value
1 Group 1 (N=100) 1.01+0.13 0.000
2 Group 2 (N=100) 1.21+0.22

Table 6

Showing comparison of left ventricle internal dimension (L.V.I.D.)

S. No. Group I.V.S.D. (CM) Mean +SD p value
1 Group 1 (N=100) 4.97+4.25 0.08
2 Group 2 (N=100) 5.24+5.72

Discussion

The following observations and results were found in our study. Age wise distribution of cases in Group 1 was 54.33+2.85 years and Group 2 subjects was 54.18+2.54 years. Genderwise distribution in Cases and subjects there were 86% Male and 14% female whereas in Control subjects in group 1 and there were 91% Male and 9% female subjects in group 2. The difference in LAD in Group 1 and Group 2 was found significant. Aortic Root dimensions difference between Group 1 and Group 2 was also found to be significant. IVSD dimensions difference between Group 1 and Group 2 it was found significant. LVID dimensions between Group 1 and Group 2 was not significant. In our study, Left ventricular systolic function was normal in all hypertensive patients although it was lower than healthy group (Group1). This result was similar to a study done by Miguel et al.19 but contrary to another study done by Akintunde et al, which showed a lower ejection fraction occurred among long term hypertensive patients.20 Left ventricular hypertrophy is a maladaptive response to chronic pressure overload and is mediated by various neurohormonal substances that independently exert trophic effects on myocytes in the heart.21 In several studies, left ventricular hypertrophy has been well documented to be a marker of morbidity and mortality22, 23 in heart disease. In our study, we found Left ventricular hypertrophy, Left ventricular mass index were significantly higher in patient with hypertension duration more than 5 year. LV mass index in hypertensive patients was 57% vs 14% in healthy group. It is well known that relation between left ventricular mass index and cardiovascular risk exists. Concentric hypertrophy is a predictor of an increased incidence of cardiovascular diseases.24, 18 In our study Hypertension duration more than 5 year was directly correlated to left ventricular mass. This was supported by another study which stated that the duration of hypertension is one of the main predictors of hypertensive cardiac damage.25 In our study LA size was significantly higher in patients. These results were similar to a study done by Millar et al., revealing a significant increase in LA Size.26

Conclusion

It can be conclude that duration of Hypertension (more than 5years) directly correlates to left ventricular mass and hence, overall function. Echocardiography is a useful technique that can detect cardiac morphologic and hemodynamic changes caused by systemic arterial hypertension. Therefore, echocardiography is a powerful tool for the evaluation of target organ damage, which is essential for the evaluation of cardiovascular risk.

Source of Funding

Self funded.

Conflicts of Interest

None declared.

References

1 

Enrico Agabiti-Rosei, Maria Lorenza Muiesan Hypertensive Left Ventricular Hypertrophy: Pathophysiological and Clinical IssuesBlood Press2001105-6288980803-7051Informa UK Limited

2 

P N Casale R B Devereux M Milner G Zullo G A Harshfield T G Pickering Value of echocardiographic left ventricular mass in predicting cardiovascular morbid events in hypertensive menAnn Int Med19861051738

3 

W B Kannel T Gordon T Offut Left ventricular hypertrophy by electrocardiogram Prevalence, incidence and mortality in the Framingham studyAnn Int Med19697189105

4 

J A Staesse I Wang G Bianchi Essential hypertensionLancet2003361162941

5 

Costantino Astarita Attila Pálinkás Emanuele Nicolai Francesco Saverio Maresca Albert Varga Eugenio Picano Dipyridamole-atropine stress echocardiography versus exercise SPECT scintigraphy for detection of coronary artery disease in hypertensives with positive exercise testJ Hypertens20011934955020263-6352Ovid Technologies (Wolters Kluwer Health)

6 

Lauro Cortigiani Emilio A. Paolini Eugenio Nannini Dipyridamole Stress Echocardiography for Risk Stratification in Hypertensive Patients With Chest PainCirc19989825285590009-7322, 1524-4539Ovid Technologies (Wolters Kluwer Health)

7 

Gabriele Fragasso Chunzeng Lu Pawel Dabrowski Paolo Pagnotta Imad Sheiban Sergio L Chierchia Comparison of stress/rest myocardial perfusion tomography, dipyridamole and dobutamine stress echocardiography for the detection of coronary disease in hypertensive patients with chest pain and positive exercise testJ Am Coll Cardiol199934244170735-1097Elsevier BV

8 

Riccardo Bigi Jeroen J Bax Ron T van Domburg Abdou Elhendy Lauro Cortigiani Arend FL Schinkel Simultaneous echocardiography and myocardial perfusion single photon emission computed tomography associated with dobutamine stress to predict long-term cardiac mortality in normotensive and hypertensive patientsJ Hypertens20052371409150263-6352Ovid Technologies (Wolters Kluwer Health)

9 

C Cuspidi S Meani C Valerio A Esposito C Sala M Maisaidi Ambulatory blood pressure, target organ damage and aortic root size in never-treated essential hypertensive patientsJ Hum Hypertens200721753180950-9240, 1476-5527Springer Science and Business Media LLC

10 

L. Cortigiani R. Bigi P. Landi F. Bovenzi E. Picano R. Sicari Prognostic implication of stress echocardiography in 6214 hypertensive and 5328 normotensive patientsEur Heart J201132121509180195-668X, 1522-9645Oxford University Press (OUP)

11 

I Maautouk B Wild W Herzog Longitudinal predictors of health related quality of life in middle aged and older adults with hypertension : results of a population based studyJ Hypertens201230136472

12 

Matteo Cameli Matteo Lisi Francesca Maria Righini Alberto Massoni Sergio Mondillo Left ventricular remodeling and torsion dynamics in hypertensive patientsInt J Cardiovasc Imaging201329179861569-5794, 1573-0743Springer Science and Business Media LLC

13 

M N Kim Park Sm W J Shim Y H Kim S A Kim D H Cho the relationship betwen aortic stiffness and left ventricular dyssynchrony in hypertensive patients with preserved left ventricular systolic functionClin Exp Hypertens2012344106

14 

Llias Karabinos Charalampos Grassos Panagiota Kostaki Echocardiography in the Evaluation of Hypertensive Patient : An invaluable tool or simply following the Routine HellenicJ Cardiol2013544757

15 

R. H Anderson ANATOMY: Clinical anatomy of the aortic rootHeart200084667030007-0769BMJ

16 

Frank Lloyd Dini Lauro Cortigiani Umberto Baldini Andrea Boni Rossella Nuti Luca Barsotti Prognostic value of left atrial enlargement in patients with idiopathic dilated cardiomyopathy and ischemic cardiomyopathyAm J Cardiol2002895518230002-9149Elsevier BV

17 

Maria Grazia Modena Nicola Muia Fabio Alfredo Sgura Rosella Molinari Annadele Castelli Rosario Rossi Left atrial size is the major predictor of cardiac death and overall clinical outcome in patients with dilated cardiomyopathy: A long-term follow-up studyClin Cardiol1997206553600160-9289, 1932-8737Wiley

18 

Margaret M. Redfield Steven J. Jacobsen John C. Burnett Douglas W. Mahoney Kent R. Bailey Richard J. Rodeheffer Burden of Systolic and Diastolic Ventricular Dysfunction in the CommunityJAMA200328921942020098-7484American Medical Association (AMA)

19 

Miguel Zabalgoita Left ventricular mass and function in primary hypertensionAm J Hypertens199695564

20 

A Akintunde O Akinwusi G Opadijo left ventricular hypertrophy ,geometric patterns and clinical correlates among treated hypertensive NigeriansPan Afr Med J2010418

21 

M L Muiesan M Salbvetti C Monteduro Left ventricular concentric geometry during treatment adversely affect cardiovascular prognosis in hypertensive patients Hypertens2004437318

22 

Graham S Hillis Jacob E Møller Patricia A Pellikka Bernard J Gersh R.Scott Wright Steve R Ommen Noninvasive estimation of left ventricular filling pressure by e/e′ is a powerful predictor of survival after acute myocardial infarctionJ Am Coll Cardiol200443336070735-1097Elsevier BV

23 

F Lepira P Kayembe M Buyamba J clinical correlates of left ventricular hypertrophy in black patients with arterial hypertensionCardiovasc J South Afr200617711

24 

Andrew S Sharp; Robyn J Tapp;Simon A Thom ;Alice V Stanton;Andrew Zambanini; Eoin O’ Brien Nish Chaturvedi: Tissue Doppler E/E’ ratio is a powerful predictor predictor of primary cardiac events in a hypertensiveEur Heart J20103174752

25 

Theresa A McDonagh Caroline E Morrison Audrey Lawrence Ian Ford Hugh Tunstall-Pedoe John JV McMurray Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban populationLancet19973509081829330140-6736Elsevier BV

26 

J Miller R O’rourke M Crawford Left atrial enlargement :An early sign of hypertensive heart diseaseAm Heart J1989117140910



jats-html.xsl

© 2020 Published by Innovative Publication Creative Commons Attribution 4.0 International License (creativecommons.org)